MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biotechnology_Genetics, Gene & Cell Therapy Companies
enGene Holdings Inc. (NASDAQ:ENGN)*
Organization & Developments: enGene Holdings
Parents
enGene Holdings Inc. (NASDAQ:ENGN)*
Children
* The company's mucosal immunotherapy platform has developed a flexible nucleotide delivery technology targeting mucosal tissues to treat numerous prevalent, chronic diseases via the induction or suppression of protein expression levels, enabling physicians and doctors to regenerate physiologic, meal-regulated insulin secretion from the gut of subjects with diabetes.
*enGene is a developer of a mucosal immunotherapy platform designed to treat inflammatory bowel disease and diabetes.
2024: enGene Holdings: Compelling Early Data Bode Well For Their Near-Term Outlook_ seekingalpha.com
2025: Detalimogene Demonstrates Improved Complete Response Rate of 62% at 6 Months
2025: enGene Holdings Inc.: Unknown Company Which Looks Like A Catch
Jumps
Finance & Acquisitions: enGene Holdings
Key People: enGene Holdings